"Science 37's mission is to enable universal access to clinical research—making it easier for patients and providers to participate from anywhere. As a pioneer of decentralized clinical trials, the Science 37 Clinical Trial Operating System (OS) supports today’s more agile clinical research designs with its full stack, end-to-end technology platform and specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators and connected devices."

During the past decade, Science 37 conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Science 37" #1 sponsor was "AOBiome LLC" with 1 trials, followed by "Acer Therapeutics Inc." with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Bond Avillion 2 Development LP" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Science 37" #1 collaborator was "Momentum Pharma" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator, "Prevail Infoworks, Inc" with 1 trials as a collaborator and "Science 37" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Science 37" are "Neoplasms" (2 trials), "Acne Vulgaris" (1 trials), "Asthma" (1 trials), "Atopic Dermatitis" (1 trials) and "Biliary Cancer" (1 trials). Many other conditions were trialed in "Science 37" in a lesser frequency.

Most popular intervention types in "Science 37" are "Drug" (9 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Alectinib" (2 trials), "ACER-002 (celiprolol) 200 mg BID" (1 trials), "AS MDI" (1 trials) and "Acyclovir 50mg buccal/topical tablet, BAYM008894/UI1614773" (1 trials). Other intervention names were less common.

The vast majority of trials in "Science 37" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Science 37". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Science 37, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Science 37, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".